Objective: To assess the usefulness of voice quality measurements as a treatment outcome in patients with laryngopharyngeal reflux (LPR)-related symptoms.
of the upper aerodigestive tract. 1 LPR affects approximately 10% of outpatients who seek otolaryngology consultation 2, 3 and 50%-80% of patients in voice centres. 4 The most frequent symptoms are globus sensation, throat clearing, cough, and hoarseness, the latter accounting for more than 80% of patients. 5, 6 To date, the LPR diagnosis remains controversial. Multichannel impedance and pHmetry studies do not seem to be a real gold standard because some evidence (ie, high false-positive and false-negative rates, interpretation difficulties, and inconsistency between pH findings and signs and symptoms) suggests that this method is not perfect. 7, 8 Moreover, this approach is expensive and annoying for many patients. As a result, some American authors consider the response of symptoms and signs to empirical medical treatment as a reliable alternative approach for confirming the diagnosis. 9, 10 This empirical approach is based on the utilisation of both the reflux symptom index (RSI > 13) and the reflux finding score (RFS > 7) at baseline, followed by treatment with dietary recommendations and proton pump inhibitors for a 3-month setup period. 9, 10 This approach makes sense if there are adequate exclusion criteria in the selection of patients. Regarding the evolution of symptoms and signs, titration/increase of the PPI dose may be proposed for three additional months. The LPR diagnosis is only considered if the patient responds ("responder patients", RSI ≤ 13 & RFS ≤ 7) after 3 or 6 months of behavioural and medical treatment. 9, 10 The diagnosis of non-responder patients remains uncertain and requires additional examinations, such as multichannel impedance and pHmetry studies. 9 Another controversy concerns the evolution of voice quality throughout the treatment period. Indeed, since the first works of Koufman in the early 1990s, only some twenty trials have studied the development of voice impairments related to LPR and the use of voice quality assessments as outcome measures. 11, 12 Some of these studies reported significant improvement in voice quality after medical treatment, 3, 11, 13 while others found mixed results. 14, 15 As shown in a previous literature review, most of these studies focused on the evolution of voice quality throughout the first 3 months, but none studied voice quality after the first 3 months of treatment, especially throughout the empirical treatment. 12 In this study, we aimed to analyse symptoms, signs, and voice quality changes throughout the 6-month course of empirical treatment and to examine the relationships among signs, symptoms, and voice quality in clinically diagnosed and confirmed LPR patients. We sought to assess the usefulness of voice quality assessments as a treatment outcome.
| MATERIALS AND METHODS

| Ethical considerations
The protocol of the study has been approved by the ethics commit- All patients were treated with diet and lifestyle behavioural changes and twice-daily proton pump inhibitors for 6 months (PPIs; 20 mg pantoprazole twice daily). Following the current clinically American validated protocol for the empirical management of LPR patients, 9,10 the treatment of responder patients (RSI ≤ 13 & RFS ≤ 7) was titrated (from 20 mg twice daily to 20 mg daily), and the therapy of low-responder/non-responder subjects was adapted (maintained/increased PPIs doses (from 20 mg twice daily to 40 mg twice daily)) after the three-first months ( Figure 1 ). Patients who
were not completely cured after 3 months were clinically assessed a second time at 6 months. With regard to some recommendations, 7, 9, 10 to confirm the diagnosis, non-responder patients received double-probe pH impedance monitoring. They stopped the PPIs
Keypoints
• Objective voice quality assessment (especially phonatory quotient, jitter and shimmer) is an interesting indicator of the LPR treatment efficiency.
• There are few clinical and voice quality improvements after 3-months of treatment because only posterior commissure hypertrophy and globus sensation similarly improve from 3 to 6 months. However, the evolutions of globus sensation and posterior commissure hypertrophy are closely linked.
• The respect of the diet behavioural changes could improve the clinical complaints by, in part, a placebo effect.
intake 1 month before the double-probe pH impedance monitoring.
We did not realise pH impedance monitoring at baseline for all patients regarding the cost of the examination and because the use of RFS > 7 and RSI > 13 followed by empirical therapeutic trial as diagnosis method has been demonstrated as a competitive diagnosis method. 17 In this context, our approach represented a cost-effective approach.
According to recent publications, 10 we defined confirmed LPR diagnosis as the positive response to the empirical therapeutic course or the objectification of LPR with pH impedance metry (resistant patients).
Concerning the diet and lifestyle behavioural changes, the patients received personalised recommendations depending on their dietary habits in the form of a recommendation (validated) grid based on Koufman's work. 18 Adherence to these recommendations was evaluated by the patient throughout the therapeutic course using a point scale ranging from 0 (non-adherent) to 10 (fully adherent to the recommendations).
| Clinical evaluations and voice quality assessment
We recorded the severity of signs and symptoms throughout the treatment with RSI and RFS. RFS was evaluated using videolaryngostroboscopy (StrobeLED-CLL-S1, Olympus Corporation, Hamburg, Germany) in a blinded manner in response to patient complaints (RSI). Perceptual voice evaluations (Grade, Roughness, Breathiness, Asthenia, Strain and Instability (GRBASI scale)) of hoarse patients were performed by a jury of five experienced speech therapists who were blinded to the time of the recording.
Aerodynamic and acoustic assessments were conducted three times: at baseline and 3 and 6 months after the treatment initiation. 
| RESULTS
From the 122 patients, 80 completed the study and 42 were excluded for many reasons (ie aerodigestive tract infections during the last month before the post-treatment consultation; absence to the medical appointment 3 months after the treatment initiation; stopping of treatment during the treatment period; diagnosis of a Parkinson disease during the treatment time; intake of neuroleptics during the last month). Eighty patients were followed up for 3 months, and 41 completed the 6-month follow-up ( Figure 1 ). The epidemiological and clinical characteristics of the included patients are described in Table 1 . Of the 41 patients who completed the study, eight were non-responders after 6 months of treatment. The diagnosis was confirmed in these patients with pH/impedance monitoring.
The mean RSI and RFS values were 22.03 AE 6.78 and 10.65 AE 2.38, respectively, at baseline, and they significantly decreased to 8.93 AE 6.13 and 4.88 AE 3.16 at 3 months, respectively, after which no further significant improvement was found (Table 2) .
After the first 3 months of treatment, all individual RSI and RFS items (excepted subglottic oedema) showed significant improvement. Some clinical images of signs of LPR are available before and after treatment in Figure 2 . From 3-6 months of treatment, we only found significant improvement of the mean values for globus sensation and posterior commissure hypertrophy (Table 2) , which were significantly correlated (P = .006; Spearman's correlation test).
Concerning adherence to the diet regimen, we found mean scores of 6.42 AE 1.80 (3 months) and 6.86 AE 1.42 (6 months). Our statistical analysis found significant negative correlations between adherence to diet and the RSI score 3 months after treatment (P = .001; Spearman's correlation test). In addition, the mean score of diet adherence was negatively correlated with the pyrosis score at 3 (P = .008) and 6-month (P = .016) post-treatment.
From the blinded evaluations of perceptual voice quality, we found significant improvements in the mean grades for dysphonia (P = .005), roughness (P = .002), strain (P = .013), and instability (P = .012) after the first 3 months of treatment ( and 250.37 AE 97.50, respectively, at 3 months post-treatment, which was significantly different (P < .034); however, these values did not improve from 3 to 6 months post-treatment (Table 4) .
Changes in acoustic measurements during the empirical treatment are described in The entire cohort was composed of 80 LPR patients. BMI, body mass index; LPR, laryngopharyngeal reflux; y, years. Changes in the RSI, RFS and voice quality measurements along the pantoprazole treatment course are described in Figure 3 . Overall,
we found a similar pattern in the evolution of RSI, RFS, and Jitt values throughout the empirical treatment. PQ and Shim had similar patterns of evolution that were not exactly similar to those of RSI, RFS and Jitt.
The study of signs (RFS) and objective voice quality assessments revealed significant correlations among Shim, NHR values and the granulation score (Table 5) . A correlation analysis for clinical characteristics, RSI, and RFS showed a negative correlation between the pyrosis sensation score and the patient's age (P = .003). Moreover, as shown in Figure 3 , the scores for globus sensation and posterior commissure hypertrophy were strongly correlated throughout the treatment course (P = .006; Spearman's correlation test). We did not find a correlation between the RSI and RFS total scores or between vocal fold oedema and objective voice quality assessments.
| DISCUSSION
The causal relationship between LPR and laryngeal disorders was originally identified at the end of the 1960s by Cherry and Marguelies. 19 Since that time, many case-controlled studies have supported the association between LPR and chronic laryngitis, hoarseness, and the development of benign laryngeal lesions. 11, 16, [20] [21] [22] Prospectively, the real impact of empirical treatment on voice quality remains unclear yielding some controversial conclusions regarding the usefulness of voice quality as treatment outcome. 12 To improve the management of LPR patients, Belafsky et al developed RSI and RFS, two reliable scales that are widely used for LPR diagnosis and follow-up throughout the world. 16 Many studies found that total scores of RSI and RFS improved from baseline to 3 or 6 months post-treatment, 3,13,16 but a few trials were really interested in the evolution of individual symptoms and signs along the empirical therapeutic course. Moreover, we often see in our clinical practice that many patients need over 3 months of treatment to completely be cured. In this study, we mainly found that most of signs and symptoms significantly improved from baseline to 6 months post-treatment with different patterns. Thus, some complaints and signs, especially globus sensation and posterior RSI is a self-administered questionnaire completed by each subject at every visit. Each of the items is related to LPR and is scored from 0 (no problem) to 5 (severe problem). The total score is found by adding all items' scores (/45). RFS is a score of LPR signs. RFS ranges from a lowest possible score of 0 (normal larynx) to a worst possible score of 26. LPR, laryngopharyngeal reflux; RFS, reflux finding score; RSI, reflux symptom index. Wilcoxon signed-rank test.
T A B L E 2 Symptoms and signs during treatment in LPR patients
Scales
Clinically diagnosed LPR patients
commissure hypertrophy, need more time to improve compared to other, supporting a benefit of continued but titrated PPIs from 3 to 6 months in patients with these findings.
Concerning the treatment, we identified a significant impact of adherence to the treatment regimen on the RSI improvement but not on the RFS improvement. This positive correlation was strongest for pyrosis sensation after 6 months of treatment. As it has long been known that diet represents an important component of the treatment's efficiency, our observations could suggest the occurrence of a 'suggestive effect' for patients who adhered to the regimen because they perceived better improvement of their main symptoms. 18 Indeed, the effect of suggestion can be defined as the psychological process by which one person guides the feelings, As observed in the evolution of RSI, RFS, and perceptual voice quality assessments, from 3 to 6 months of treatment, we did not find significant evolution of acoustic or aerodynamic measures in LPR patients. In other words, voice results remained stable from 3 to 6 months. No previous study has examined voice quality changes after 3 months of treatment, which limits our literature comparisons.
The lack of improvement of voice quality and the specified clinical improvement (ie globus and posterior commissure hypertrophy) from 3 to 6 months support the current cost-effective therapeutic scheme consisting of an initial treatment of 3 months with titration for the 3 additional months.
As previously reported, 7, 12, 26 28 In other words, instability or a deterioration of PQ could be more strongly associated with an increase in the Shim values.
Our results also exhibited that the evolution of NHR from 3 to 6 months differed from the evolution of jitter, shimmer, RSI and RFS. This unexpected evolution particularly supports that NHR measurement is less representative of the clinical evolution throughout the empirical treatment and less useful as therapeutic outcome.
However, Hamdan et al found similar findings about the NHR evolution along the treatment in comparison with other acoustic measurements. 14 In a general way, the similar evolution of RSI, RFS, jitter and perceptual voice strengthens the interest of these evaluations as LPR therapeutic outcome.
Finally, to study the pathophysiological mechanisms underlying the voice quality alterations related to LPR, we conducted correlation analysis among videolaryngostroboscopic signs and acoustic measurements. First, as found in another study, 3 we did not identify a relationship between vocal fold oedema and any acoustic measurements, contradicting the notion that vocal fold oedema is the causative factor of irregular vocal fold vibrations leading to hoarseness. As described in a recent pathophysiological review, other findings could explain the development of hoarseness related to LPR. Indeed, the occurrence of microtraumatism, thickening, ulcerations and keratosis of the margin of the vocal folds, and inflammatory modifications of the Reinke space could modify the vocal folds' biomechanical properties resulting in hoarseness. 20 In the present study, we did not 
